TY - JOUR
T1 - A simplified high‐performance liquid chromatographic method for direct determination of warfarin enantiomers and their protein binding in stroke patients
AU - Cai, Wei M.
AU - Hatton, Jimmi
AU - Pettigrew, L. Creed
AU - Dempsey, Robert J.
AU - Chandler, Mary H.H.
PY - 1994/10
Y1 - 1994/10
N2 - A simplified method for direct determination of warfarin enantiomers by high-pressure liquid chromatography with fluorescence detection has been developed. This method involves solid phase extraction of warfarin in plasma, precolumn derivatization to form diastereoisomeric esters, and post-column reaction to discriminate each enantiomer separately. Ultrafiltration was employed in the separation of unbound warfarin enantiomers. Twelve plasma samples from six stroke patients taking warfarin regularly were analyzed. The average concentration of total warfarin was 0.47 ± 0.17 mg/L for the S-isomer and 0.69 ± 0.18 mg/L for the R-isomer. The average protein binding was 99.67 ± 0.33% for S-warfarin and 99.44 ± 0.33% for R-warfarin. This methodology provides a quick and reliable technique for determining enantiomeric protein binding of warfarin in clinical settings.
AB - A simplified method for direct determination of warfarin enantiomers by high-pressure liquid chromatography with fluorescence detection has been developed. This method involves solid phase extraction of warfarin in plasma, precolumn derivatization to form diastereoisomeric esters, and post-column reaction to discriminate each enantiomer separately. Ultrafiltration was employed in the separation of unbound warfarin enantiomers. Twelve plasma samples from six stroke patients taking warfarin regularly were analyzed. The average concentration of total warfarin was 0.47 ± 0.17 mg/L for the S-isomer and 0.69 ± 0.18 mg/L for the R-isomer. The average protein binding was 99.67 ± 0.33% for S-warfarin and 99.44 ± 0.33% for R-warfarin. This methodology provides a quick and reliable technique for determining enantiomeric protein binding of warfarin in clinical settings.
KW - Enantiomers
KW - High-pressure liquid chromatography
KW - Plasma protein binding
KW - Stroke
KW - Ultrafiltration
KW - Warfarin
UR - http://www.scopus.com/inward/record.url?scp=0028146219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028146219&partnerID=8YFLogxK
U2 - 10.1097/00007691-199410000-00012
DO - 10.1097/00007691-199410000-00012
M3 - Article
C2 - 7846751
AN - SCOPUS:0028146219
SN - 0163-4356
VL - 16
SP - 509
EP - 512
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
IS - 5
ER -